Related references
Note: Only part of the references are listed.The Taccalonolides; Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
April L. Risinger et al.
CANCER RESEARCH (2008)
STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells
Simon P. Newman et al.
CLINICAL CANCER RESEARCH (2008)
Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?
Pascal Seve et al.
LANCET ONCOLOGY (2008)
The roles of cys124 and ser239 in the functional properties of human βIII tubulin
Patrick A. Joe et al.
CELL MOTILITY AND THE CYTOSKELETON (2008)
Melanoma cell sensitivity to Docetaxel-induced apoptosis is determined by class III beta-tubulin levels
Nizar M. Mhaidat et al.
FEBS LETTERS (2008)
Class III β-tubulin mediates sensitivity to chemotherapeutic drugs in non-small cell lung cancer
Pei Pei Gan et al.
CANCER RESEARCH (2007)
Cytoskeleton and paclitaxel sensitivity in breast cancer:: The role of β-tubulins
Stefania Tommasi et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: Synthesis, in vitro SAR, protein crystallography, and in vivo activity
Mathew P. Leese et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Predictive factors for response to docetaxel in human breast cancers
Shinzaburo Noguchi
CANCER SCIENCE (2006)
A-ring-substituted estrogen-3-O-sulfamates:: Potent multitargeted anticancer agents
MP Leese et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Expression of class III β-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy
P Sève et al.
CLINICAL CANCER RESEARCH (2005)
Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer
Angelo Paradiso et al.
ANNALS OF ONCOLOGY (2005)
βIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability
K Kamath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The seco-taxane IDN5390 is able to target class III β-tubulin and to overcome paclitaxel resistance
C Ferlini et al.
CANCER RESEARCH (2005)
Anti-cancer activities of novel D-ring modified 2-substituted estrogen-3-O-sulfamates
MP Leese et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Expression of class III β-tubulin reduces microtubule assembly and confers resistance to paclitaxel
M Hari et al.
CELL MOTILITY AND THE CYTOSKELETON (2003)
Growth inhibition of multi-drug-resistant breast cancer cells by 2-methoxyoestradiol-bis-sulphamate and 2-ethyloestradiol-bis-sulphamate
RN Suzuki et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Mutational analysis of the beta-tubulin gene in lung cancer
J Tsurutani et al.
LUNG CANCER (2002)
Refined structure of αβ-tubulin at 3.5 A resolution
J Löwe et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Modulation of endogenous β-tubulin isotype expression as a result of human βIII cDNA transfection into prostate carcinoma cells
S Ranganathan et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
